These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28978205)

  • 1. All-cause costs increase exponentially with increased chronic kidney disease stage.
    Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
    Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.
    Polson M; Lord TC; Kangethe A; Speicher L; Farnum C; Brenner M; Oestreicher N; Alvarez P
    J Manag Care Spec Pharm; 2017 Apr; 23(4-a Suppl):S2-S9. PubMed ID: 28436256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 4. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
    Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
    J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs.
    Vekeman F; Magestro M; Karner P; Duh MS; Nichols T; van Waalwijk van Doorn-Khosrovani SB; Zonnenberg BA
    J Med Econ; 2015; 18(12):1060-70. PubMed ID: 26201433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
    Patel AR; Dombrovskiy VY; Vogel TR
    Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study.
    Burke JP; Hunsche E; Régulier E; Nagao M; Buzinec P; Drake Iii W
    Am J Manag Care; 2015 Jan; 21(3 Suppl):s47-58. PubMed ID: 25734573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare resource use and costs associated with chronic kidney disease in US private insurance patients with multiple myeloma.
    Bhowmik D; Song X; Intorcia M; Kent ST; Shi N
    J Oncol Pharm Pract; 2019 Jun; 25(4):855-864. PubMed ID: 29661050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
    Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
    J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care costs associated with hospital acquired complications in patients with chronic kidney disease.
    Bohlouli B; Jackson T; Tonelli M; Hemmelgarn B; Klarenbach S
    BMC Nephrol; 2017 Dec; 18(1):375. PubMed ID: 29282006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study of the quality of care for chronic kidney disease: a Buffalo and Albany, New York metropolitan area study.
    Arora P; Elkin PL; Eberle J; Bono JJ; Argauer L; Murray BM; Ram R; Venuto RC
    BMC Nephrol; 2015 Dec; 16():199. PubMed ID: 26634443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.
    Laliberté F; Bookhart BK; Vekeman F; Corral M; Duh MS; Bailey RA; Piech CT; Lefebvre P
    J Manag Care Pharm; 2009 May; 15(4):312-22. PubMed ID: 19422271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage.
    Gagnon-Sanschagrin P; Liang Y; Sanon M; Oberdhan D; Guérin A; Cloutier M
    J Med Econ; 2021; 24(1):193-201. PubMed ID: 33464936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Study of Index and Readmission Mortality and Costs for Thoracic Endovascular Aortic Repair in Patients With Renal Disease.
    Sanaiha Y; Kavianpour B; Downey P; Morchi R; Shemin RJ; Benharash P
    Ann Thorac Surg; 2020 Feb; 109(2):458-464. PubMed ID: 31336063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden and Cost of Caring for US Veterans With CKD: Initial Findings From the VA Renal Information System (VA-REINS).
    Saran R; Pearson A; Tilea A; Shahinian V; Bragg-Gresham J; Heung M; Hutton DW; Steffick D; Zheng K; Morgenstern H; Gillespie BW; Leichtman A; Young E; O'Hare AM; Fischer M; Hotchkiss J; Siew E; Hynes D; Fried L; Balkovetz D; Sovern K; Liu CF; Crowley S; ;
    Am J Kidney Dis; 2021 Mar; 77(3):397-405. PubMed ID: 32890592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying chronic kidney disease stage 3 with excess disease burden.
    Campbell A; Chu L; Crittenden S; Sutton A; Boehler A
    Am J Manag Care; 2024 Jun; 30(6):e172-e177. PubMed ID: 38912931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.